Michaela Ott serves as Executive at Medite Cancer Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Michaela Ott has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 5, 2015 involved purchasing 156,250 shares valued at $0.
Michaela Ott currently holds 7,500,000 shares of Medite Cancer Diagnostics, Inc. (MDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michaela Ott has been a net neutral trader of MDIT stock. They have purchased $0 and sold $0 worth of shares.
Michaela Ott's most recent insider trade was on Oct 5, 2015, when they purchased 156,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |